The strain types involved and the extent to which interspecies transmission occurs have still to be elucidated. Evidence also is accumulating regarding the existence of potential wildlife reservoirs, for example, infected

rabbits appear to be a particular problem in some areas of Scotland [3] but the role of such wildlife reservoirs in the epidemiology of the disease Chk inhibitor has still to be clarified. Our knowledge and understanding of the epidemiology of Map has been hindered for many years by our inability to discriminate Map from the environmental species of Mycobacterium avium (M. avium) and to differentiate between Map isolates from different host species and different geographic locations. Recent advances in molecular biology have led to the refinement and development of molecular typing methods with sufficient discriminatory power to differentiate between M. avium subspecies and different Map isolates [8]. Genome analyses have revealed two major strain groups EGFR inhibitor designated ‘Type I’, or ‘sheep

or S type’ and ‘Type II’ or ‘cattle or C type’. A sub-type of Type I strains designated ‘Type III’ or ‘intermediate or I type’ is found in sheep and goats. All three of these strain types can be differentiated by restriction fragment length polymorphism coupled with hybridization to IS900 (IS900-RFLP) [9, 10] or pulsed-field gel electrophoresis (PFGE) analyses [11, 12] and by a PCR assay based on single nucleotide polymorphisms in the gyrA and gyrB genes [13]. Single nucleotide

polymorphisms in the IS1311 Repotrectinib in vivo element also distinguish three types designated ‘S’ (sheep), ‘C’ (cattle) and ‘B’ (bison) [14, 15]. In this case the assay cannot distinguish between Types I and III and the ‘B’ type is a sub-type of Type II strains. In silico genome comparisons and techniques such as representational difference analysis and microarray analysis have identified sequence polymorphisms unique to either Type I or II strains and these have been used to develop PCRs for discriminating these strain groups [16–21]. The purpose of this study was to investigate the molecular diversity of Map isolates from a variety of hosts across Europe to enhance our understanding of the host range and distribution of the organisms and Clomifene assess the potential for interspecies transmission. Previous studies have revealed limited genetic diversity; therefore, to maximise strain differentiation we evaluated several different molecular typing techniques in isolation and in combination; IS900-RFLP, PFGE and PCR-based techniques including amplified fragment length polymorphisms (AFLP) and mycobacterial interspersed repeat unit-variable number tandem repeat (MIRU-VNTR). Results AFLP typing was performed at the Central Institute of Wageningen University, Lelystad, The Netherlands and MIRU-VNTR at INRA, Nouzilly, France.